Develop a novel, low cost, blood storage system that will deliver red cells of higher quality, thereby reducing the harmful consequences of transfusion therapy. Hasp is designed for maximum…
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN268201300045C
- Awardee
-
New Health Sciences, Inc. UEI CC3QRDB7EYX7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,660,011
Award facts
- Opportunity
-
- PHS20131 Solicitation number
- Solicitation of the national institutes of health and the centers for disease control and prevention for small business innovation research contract proposals Award Notice · Posted Nov 1, 2012
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Award Notice · Posted Jul 30, 2012
- Contract value 100% obligated
- $1,660,011.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 9 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Westlake, MD 20817, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,464,886 | |
| Change Order | $0 | |
| Original award | $195,127 |
About this award
This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to New Health Sciences, Inc. (doing business as Hemanext Inc.), a small business manufacturer. The $1,660,011.00 contract is for the development of a novel, low-cost blood storage system that will deliver higher quality red blood cells, thereby reducing the harmful consequences of transfusion therapy. This contract is part of the SBIR (Small Business Innovation Research) Phase I program, under topic 74 for an RBC (Red Blood Cell) storage system to minimize storage lesions. The contract has a total small business set-aside designation and is a cost-plus-fixed-fee definitive contract.
Description
Develop a novel, low cost, blood storage system that will deliver red cells of higher quality, thereby reducing the harmful consequences of transfusion therapy. Hasp is designed for maximum ease-of-integration into existing blood bank operating practices with minimal alteration in procedures, equipment or cost.
Quick answers
Who was awarded contract HHSN268201300045C?
HHSN268201300045C was awarded to New Health Sciences, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 30, 2013.
How much is contract HHSN268201300045C worth?
The government has obligated $1,660,011 on HHSN268201300045C.
Was contract HHSN268201300045C competed?
The extent of competition for HHSN268201300045C was full and open competition after exclusion of sources. The government received 9 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award